Hi PLT'ers,Whilst not wanting to distract from Dabru's post...

Hi PLT'ers,

Whilst not wanting to distract from Dabru's post (have a read of the link he mentioned, it's an important read) ...

I somehow managed to find this on the 2nd page of a Google search on 'Polartechnics CerviScreen' of all things!

I couldn't believe it ... this is primo info, for us information starved PLT / HC'ites.

The link is to a 19 page powerpoint presentation by Ben Dillon, dated May 2008 (and presumably very new given that no one else seems to have mentioned it to date). The link is:-
http://ausmedtech08.com.au/uploads/docs/Speaker%20Presentations/14.15%20-%20Ben%20Dillan%20PLT%20AusMedTech.pdf

Although it appears to be a little 'out there' without Ben actually guiding us through it (why weren't we invited?!), it does shed some much-needed light on quite a few things, including current sales and projected sales from here onwards. A slight warning sign however appears right at the end, where it lists 'Potential Short Term Funding' as being cash in hand, options, but then 'PLT Placement Capacity' as 9m ... let's hope the profits kick in well before that avenue needs to be explored.

Overall it is very bullish, and predicts more than a doubling of market capitalisation by the end of this year (that wouldn't be hard, given the current SP!). Enjoy ... I look forward to your various observations, please share them with the forum ...

Cheers.

p.s. interesting that it included Chlamydia and Gonorrhoea in addition to HPV for CerviScreen's molecular diagnostic test ... these are listed as future applications for Genera (GBI, newly successful IPO) ... obviously the technology suits itself to testing these other diseases (I assume there is no link to GBI implied, but it's interesting that it will be able to compete in those areas as well)